Resilient Lifescience, Inc. — Form D
Resilient Lifescience, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-23. The offering totals $5.0M, of which $600K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-12-23
- Form: D
- Accession: 0001928983-22-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $600K
- Remaining: $4.4M
- Investors: 2
- Date of first sale: 2022-12-14
- Revenue range: Decline to Disclose
- SEC file number: 021-468689
Issuer
- Name: Resilient Lifescience, Inc.
- CIK: 0001928983
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 100 S. COMMONS, PITTSBURGH, PA, 15212
- Phone: 978-407-1703
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Bradford Holden | Director | Pittsburgh, PA |
| Charles Proctor | Director | Pittsburgh, PA |
| Bradford Holden | Executive Officer | Pittsburgh, PA |
| Charles Proctor | Executive Officer | Pittsburgh, PA |
Other filings by this issuer (1)
More